Literature DB >> 15803057

Choice of fluid influences outcome in prolonged hypotensive resuscitation after hemorrhage in awake rats.

Michael T Handrigan1, Timothy B Bentley, James D Oliver, Lindita S Tabaku, J Robert Burge, James L Atkins.   

Abstract

Hypotensive resuscitation (Hypo) has been considered an alternate resuscitation strategy in clinical settings that prevent the application of standard Advanced Trauma Life Support care. However, validation of this approach when used for prolonged periods of time remains to be demonstrated. The purpose of this study was to evaluate prolonged Hypo as an alternative to standard resuscitation using various currently available resuscitative fluids. Unanesthetized, male Sprague-Dawley rats underwent computer-controlled hemorrhagic shock and resuscitation. There were six experimental groups; nonhemorrhage (NH), nonresuscitated control (C), Hypo with lactated Ringer's (HypoLR), Hypo with Hextend, 6% hydroxyethyl starch in a balanced salt solution (HEX), Hypo with PolyHeme, a polymerized hemoglobin solution (HBOC), or standard resuscitation with LR (StandLR). Animals were bled over 15 min to a mean arterial blood pressure (MAP) of 40 mmHg where the blood pressure (BP) was held for 30 min. Hypo groups were resuscitated to 60 mmHg for 4 h followed by further resuscitation to 80 mmHg. StandLR rats were resuscitated to 80 mmHg immediately after the hemorrhage period. Animals were monitored until death or they were sacrifice at 24 h. Prolonged Hypo with HEX or LR resulted in a trend toward improved 24-h survival compared with C (71%, 65%, and 48%, respectively), and performed at least as well as StandLR (58% survival). HEX required significantly less intravenous fluid (0.7x total estimated blood volume [EBV]) compared with HypoLR (1.9x EBV) and StandLR (3.2x EBV) (P < 0.05). Although HBOC required the smallest fluid volume (0.4x EBV), survival was no better than C and it resulted in the most significant acidosis. These results support the decision to use Hextend for Hypo, a strategy currently being applied on the battlefield.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15803057     DOI: 10.1097/01.shk.0000156667.04628.1f

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  14 in total

1.  Survival and inflammatory responses in experimental models of hemorrhage.

Authors:  Bolin Cai; Weihong Dong; Susan Sharpe; Edwin A Deitch; Luis Ulloa
Journal:  J Surg Res       Date:  2009-12-09       Impact factor: 2.192

2.  Hemoglobin-based oxygen carriers in trauma care: scientific rationale for the US multicenter prehosptial trial.

Authors:  Ernest E Moore; Aaron M Cheng; Hunter B Moore; Tomohiko Masuno; Jeffrey L Johnson
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

3.  Ethyl pyruvate improves survival in awake hemorrhage.

Authors:  Bolin Cai; Michael Brunner; Haichao Wang; Ping Wang; Edwin A Deitch; Luis Ulloa
Journal:  J Mol Med (Berl)       Date:  2009-01-28       Impact factor: 4.599

4.  Ethyl pyruvate prevents inflammatory responses and organ damage during resuscitation in porcine hemorrhage.

Authors:  WeiHong Dong; Bolin Cai; Geber Peña; Vadim Pisarenko; Gergely Vida; Danielle Doucet; Marlon Lee; Susan Sharpe; Qi Lu; Da-Zhong Xu; Laura Ramos; Edwin A Deitch; Luis Ulloa
Journal:  Shock       Date:  2010-08       Impact factor: 3.454

Review 5.  A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers.

Authors:  Jiin-Yu Chen; Michelle Scerbo; George Kramer
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

6.  Prehospital intravenous fluid is associated with increased survival in trauma patients.

Authors:  David A Hampton; Löic J Fabricant; Jerry Differding; Brian Diggs; Samantha Underwood; Dodie De La Cruz; John B Holcomb; Karen J Brasel; Mitchell J Cohen; Erin E Fox; Louis H Alarcon; Mohammad H Rahbar; Herb A Phelan; Eileen M Bulger; Peter Muskat; John G Myers; Deborah J del Junco; Charles E Wade; Bryan A Cotton; Martin A Schreiber
Journal:  J Trauma Acute Care Surg       Date:  2013-07       Impact factor: 3.313

7.  Effects of In vitro hemodilution, hypothermia and rFVIIa addition on coagulation in human blood.

Authors:  Daniel N Darlington; Igor Kremenevskiy; Anthony E Pusateri; Michael R Scherer; Chriselda G Fedyk; Bijan S Kheirabaldi; Angel V Delgado; Michael A Dubick
Journal:  Int J Burns Trauma       Date:  2012-03-15

8.  The USA Multicenter Prehosptial Hemoglobin-based Oxygen Carrier Resuscitation Trial: scientific rationale, study design, and results.

Authors:  Ernest E Moore; Jeffrey L Johnson; Frederick A Moore; Hunter B Moore
Journal:  Crit Care Clin       Date:  2009-04       Impact factor: 3.598

9.  Anti-inflammatory resuscitation improves survival in hemorrhage with trauma.

Authors:  Bolin Cai; Edwin A Deitch; Daniel Grande; Luis Ulloa
Journal:  J Trauma       Date:  2009-06

10.  Resuscitation of haemorrhagic shock with normal saline vs. lactated Ringer's: effects on oxygenation, extravascular lung water and haemodynamics.

Authors:  Charles R Phillips; Kevin Vinecore; Daniel S Hagg; Rebecca S Sawai; Jerome A Differding; Jennifer M Watters; Martin A Schreiber
Journal:  Crit Care       Date:  2009-03-04       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.